|
 |
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
 |
 |
|
|
a Medical Department, Brookhaven National Laboratory, Upton, New York, USA b Department of Anesthesiology, Stony Brook University, New York, New York, USA c Department of Chemistry and Biomedical Engineering, The Florida State University, Tallahassee, Florida, USA d The National High Magnetic Field Laboratory, Tallahassee, Florida, USA e Department of Neuroscience, Mount Sinai School of Medicine, New York, New York, USA
Key Words: MR microscopy • phenotyping • imaging • mice • Alzheimer's disease • model
Address for correspondence: Helene Benveniste, M.D., Ph.D., Brookhaven National Laboratory, Medical Department, Bldg. 490, 30 Bell Avenue, Upton, NY 11973. Voice: 631-344-7006; fax: 631-344-5260. benveniste{at}bnl.gov
The wide variety of transgenic mouse models of Alzheimer's disease (AD) reflects the search for specific genes that influence AD pathology and the drive to create a clinically relevant animal model. An ideal AD mouse model must display hallmark AD pathology such as amyloid plaques, neurofibrillary tangles, reactive gliosis, dystrophic neurites, neuron and synapse loss, and brain atrophy and in parallel behaviorally mimic the cognitive decline observed in humans. Magnetic resonance (MR) microscopy (MRM) can detect amyloid plaque load, development of brain atrophy, and acute neurodegeneration. MRM examples of AD pathology will be presented and discussed. What has lagged behind in preclinical research using transgenic AD mouse models is functional phenotyping of the brain; in other words, the ability to correlate a specific genotype with potential aberrant brain activation patterns. This lack of information is caused by the technical challenges involved in performing functional MRI (fMRI) in mice including the effects of anesthetic agents and the lack of relevant "cognitive" paradigms. An alternative approach to classical fMRI using external stimuli as triggers of brain activation in rodents is to electrically or pharmacologically stimulate regions directly while simultaneously locally tracking the activated interconnected regions of rodents using, for example, the manganese-enhanced MRI (MEMRI) technique. Finally, transgenic mouse models, MRM, and future AD research would be strengthened by the ability to screen for AD-like pathology in other non-AD transgenic mouse models. For example, molecular biologists may focus on cardiac or pulmonary pathologies in transgenic mice models and as an incidental finding discover behavioral AD phenotypes. We will present MRM data of brain and cardiac phenotyping in transgenic mouse models with behavioral deficits.
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||
 |
 |
